EyePoint Pharmaceuticals
EYPT
#5228
Rank
C$2.04 B
Marketcap
C$24.69
Share price
0.45%
Change (1 day)
97.16%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Total assets

Total assets on the balance sheet as of September 2025 : C$0.34 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's total assets are C$0.34 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

EyePoint Pharmaceuticals - Total assets on balance sheet (from 2003 to 2025)

Total assets by year

Year Total assets Change
2024-12-31C$0.60 B27.47%
2023-12-31C$0.47 B92.49%
2022-12-31C$0.24 B-27.09%
2021-12-31C$0.33 B187.02%
2020-12-31C$0.11 B22.71%
2019-12-31C$95.3 M
2018-06-30C$94.24 M288.43%
2017-06-30C$24.26 M-40.78%
2016-06-30C$40.97 M1.46%
2015-06-30C$40.38 M66.93%
2014-06-30C$24.19 M41.62%
2013-06-30C$17.08 M-18.54%
2012-06-30C$20.97 M-53.81%
2011-06-30C$45.4 M-0.29%
2010-06-30C$45.53 M6.82%
2009-06-30C$42.63 M-24.97%
2008-06-30C$56.82 M-47.7%
2007-06-30C$0.10 B-44.03%
2006-06-30C$0.19 B124.16%
2005-06-30C$86.6 M131.85%
2004-06-30C$37.35 M475.27%
2003-06-30C$6.49 M
2001-06-30C$7.14 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NRC Health
NRC
C$0.18 B-46.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
C$0.37 M-99.89% Bahamas